Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma or diffuse large B-cell lymphoma: Updated results of a Phase 1b/2 study Meeting Abstract

   

Authors:	Matasar, M.; Herrera, A. F.; Kamdar, M.; Mehta, A.; Assouline, S.; Fleury, I.; Kim, T. M.; Kim, W. S.; Bosch, F.; Radford, J.; Flowers, C. R.; Bu, L.; Hong, W. J.; Sehn, L. H.
Abstract Title:	Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma or diffuse large B-cell lymphoma: Updated results of a Phase 1b/2 study
Meeting Title:	22nd Congress of the European Hematology Association (EHA)
Journal Title:	Haematologica
Volume:	102
Issue:	Suppl. 2
Meeting Dates:	2017 Jun 22-25
Meeting Location:	Madrid, Spain
ISSN:	0390-6078
Publisher:	Ferrata Storti Foundation
Date Published:	2017-06-26
Start Page:	173
Language:	English
ACCESSION:	WOS:000404127001362
PROVIDER:	wos
PMCID:	PMC5492673
Notes:	Meeting Abstract: S468 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/114663